You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter.
Under the agreement, MRM Proteomics has granted Biodesix rights to use its iMALDI mass spectrometry technologies to develop blood-based tests for lung cancer.
The new version of the mass spectrometry-based system adds 144 microbial species to its database and includes new tools for sample preparation.
With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms.
The firms will work to implement MALDI PharmaPulse high-throughput mass spec instrumentation at AMRI's Integrated Drug Discovery Center.
Certain alleles at two SNP sites in TP53 coincided with decreased colorectal cancer risk or an earlier time of disease onset in a study of almost 300 Taiwanese individuals with Lynch syndrome.
The mass spectrometry services and instrument firm is working with a Yale pathologist to develop proteomic tests for solid tumors.
Unlike MALDI-based microbial ID efforts from companies like Bruker and BioMérieux, the SimulTOF effort is focused not on clinical work but rather research uses.
Conference attendees discussed the growing number of MALDI-TOF applications while recognizing that LDT regulation poses a particular threat to mass spec-based tests.
NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded Labcyte $1 million to create a process for detecting cancer-associated proteins in samples, the company announced today.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.